Banyan Biomarkers Inc. of Alachua, Fla, was awarded a $12,950,816 cost-plus-fixed-fee, non-option-eligible, multi-year contract modification (P00015) of contract (W81XWH-10-C-0251) for a within scope increase to develop a mild/moderate traumatic brain injury assay for use on the Johnson & Johnson/Ortho Clinical Diagnostics VITROs(r) MicroWell device to analyze clinical trial samples.
Performance locations will be Rochester, N.Y., Alachua, Fla., and Carlsbad, Calif., with funding from fiscal 2012 and 2013 research development testing and evaluation funds. This contract was a non-competitive acquisition with one bid received. The U.S. Army Medical Research Acquisition Activity, Frederick, Md., is the contracting activity.
Source: Defense.gov
From Our Partners
